According to Amwell, re-platforming is driving more use of telehealth tools.
After its breakout performance during the pandemic, telehealth is aiming for a new position in the healthcare mix, as seen by Amwell’s performance towards the end of 2022.
Amwell Chairman and CEO Ido Schoenberg focused the majority of his remarks on the company’s re-platforming to its Converge solution during the company’s fourth quarter 2022 earnings call on Wednesday (Feb. 22), stating that visits on Converge increased from 16% of total visits in Q3 to 28% of total visits in the quarter ended Dec. 31.
“It is becoming evident to me that we made the right decision to re-platform our product,” Schoenberg said, highlighting the retention of significant clients including Elevance Health and Northwell Health. “Digital-first care is quickly becoming the major highway for a range of care modalities given by all sorts of providers and services,” he continued, “and our role in this transformation is crucial.”
Data from the February study “The ConnectedEconomy™ Monthly Report: Digitally Divided — Work, Health and the Income Gap” found an income-based divide in consumers using digital healthcare, reporting “high-income consumers are now twice as likely as low-income consumers to use digital to access healthcare services.
